Tudorza Pressair (TU-door-za, aclidinium), for chronic obstructive pulmonary disease (COPD)

December 2012

You'll soon see a new inhaler, Tudorza Pressair (TU-door-za, aclidinium), for chronic obstructive pulmonary disease (COPD).

Think of Tudorza Pressair as an alternative to Spiriva (tiotropium). Both work about the same to keep airways open to PREVENT wheezing, coughing, and other COPD symptoms.

Plus, they both cost around $200 for a month's supply.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote